Aromatase and amphiregulin are correspondingly expressed in human liver cancer cells

Annals of the New York Academy of Sciences

Volumn 1155, Issue , 2009, Pages 252-256

  Miceli, Vitale ^a   Cervello, Melchiorre ^b   Azzolina, Antonina ^b   Montalto, Giuseppe ^c   Calabrò, Maurizio ^a   Carruba, Giuseppe ^a  

^a ARNAS Civico   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

Author keywords

Amphiregulin (AREG); Aromatase (Aro); Estrogen receptor (ER); Human hepatocellular carcinoma (HCC)

Indexed keywords

AMPHIREGULIN; AROMATASE; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR ALPHA46; ESTROGEN RECEPTOR ALPHA66; MESSENGER RNA; UNCLASSIFIED DRUG;

CANCER CELL; CELL LINE; CELL PROLIFERATION; CELL STRAIN HEPG2; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIVER CANCER; LIVER CELL CARCINOMA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN LOCALIZATION; PROTEIN VARIANT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; WILD TYPE;

EID: 61649119227     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.03695.x     Document Type: Conference Paper

References (14)

1. Lui, W.Y., H.L. Lin, et al. 2000. Male predominance in hepatocellular carcinoma: New insight and a possible therapeutic alternative. Med. Hypotheses 55 : 348 350.
2. Nagasue, N., A. Ito, et al. 1986. Estrogen receptors in hepatocellular carcinoma. Cancer 57 : 87 91.
3. Gallo, C., E. De Maio, et al. and the CLIP (Cancer of the Liver Italian Programme) Investigators. 2006. Tamoxifen is not effective in good prognosis patients with hepatocellular carcinoma. BMC Cancer 6 : 196.
4. Villa, E., L. Camellini, et al. 1995. Variant estrogen receptor messenger RNA species detected in human primary hepatocellular carcinoma. Cancer Res. 55 : 498 500.
5. Barkhem, T., C. Andersson-Ross, et al. 1997. Characterization of the "estrogenicity" of tamoxifen and raloxifene in HepG2 cells: Regulation of gene expression from an ERE controlled reporter vector versus regulation of the endogenous SHBG and PS2 genes. J. Steroid Biochem. Mol. Biol. 62 : 53 64.
6. Giannitrapani, L., M. Soresi, et al. 2006. Sex hormones and risk of liver tumor. Ann. N. Y. Acad. Sci. 1089 : 228 236.
7. Castagnetta, L.A.M., B. Agostara, et al. 1995. Local estrogen formation by nontumoral, cirrhotic, and malignant human liver tissues and cells. Cancer Res. 63 : 5041 5045.
8. Berasain, C., E.R. García-Trevijano, et al. 2005. Amphiregulin: An early trigger of liver regeneration in mice. Gastroenterology 128 : 424 432.
9. Berasain, C., E.R. García-Trevijano, et al. 2005. Novel role for amphiregulin in protection from liver injury. J. Biol. Chem. 280 : 19012 19020.
10. Castillo, J., E. Erroba, et al. 2006. Amphiregulin contributes to the transformed phenotype of human hepatocellular carcinoma cells. Cancer Res. 66 : 6129 6138.
11. Berasain, C., J. Castillo, et al. 2007. Amphiregulin: A new growth factor in hepatocarcinogenesis. Cancer Lett. 254 : 30 41.
12. Llovet, J., S. Ricci, et al. 2007. For the SHARP Investigators Study Group. Sorafenib improves survival in advanced hepatocellular carcinoma: Results of a phase III randomized placebo-controlled trial (SHARP trial). J. Clin. Oncol. 2007: ASCO Annual Meeting Proceedings 25 (Suppl 1 LBA1.
13. Flouriot, G., H. Brand, et al. 2000. Identification of a new isoform of the human estrogen receptor-alpha (hER-α) that is encoded by distinct transcripts and that is able to repress hER-α activation function 1. EMBO J. 19 : 4688 4700.
14. Li, L., P. Haynes, et al. 2003. Plasma membrane localization and function of the estrogen receptor α variant (ER46) in human endothelial cells. Proc. Natl. Acad. Sci. USA 100 : 4807 4812.